generic glp 1 agonists Diabetes patients now have access to first GLP-1 medication: ‘More accessible and affordable’ generic glp 1 agonists FDA

The first GLP-1 drugs developed are self-administered via daily or weekly subcutaneous (under the skin) injections using a pre-filled pen

McClean PL, Jalewa J, Hlscher C

Several mechanisms may be involved in this potential association, some of which include sudden weight loss and hyperactivity of the hypothalamic-pituitary-adrenal axis

While its effective for blood sugar control, its weight loss results are modest compared to newer options

In addition, it is recommended that the duration of future clinical trials of GLP-1RAs for AD extend to 2 to 3 years to evaluate long-term outcomes, including changes in cognition, activities of daily living, instrumental activities of daily living, and biomarkers for tau and A

The child of a nurse and doctor, Weber grew up in Oshkosh in Wisconsin and did a BSc in Chemistry at the University of Notre Dame and then a doctorate at Harvard University